Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study
Donald A. Richards, Paul R. Kuefler, Carlos Becerra, Lalan S. Wilfong, Robert H. Gersh, Kristi A. Boehm, Feng Zhan, Lina Asmar, Scott P. Myrand, Rebecca R. Hozak, Luping Zhao, John F. Gill, Brian P. MVolume:
29
Language:
english
Pages:
10
DOI:
10.1007/s10637-009-9307-8
Date:
February, 2011
File:
PDF, 220 KB
english, 2011